Course Description
This session is not available for streaming.
Therapeutic Case Report Award:
-
1:00-1:15 PM: Austin De La Cruz, PharmD, BCPP, Clinical Assistant Professor, University of Houston College of Pharmacy, Houston, TX
A Search and Seizure for Relief- The Effective Pharmacological Treatment of Psychogenic Non-Epileptic Seizures (PNES) with Escitalopram -
1:15-1:30 PM: Jonathan Leung, PharmD, BCPP, BCPS, Psychiatric Clinical Pharmacist, Mayo Clinic, Rochester, MN
Inflammation with Intolerance after Early Clozapine Exposure: A Rationale for Early CRP Monitoring Beyond Myocarditis
Innovative Practices Award:
-
1:30-1:45 PM: Heng Chang, PharmD, BCPS, Advance Practice Pharmacist, Whiteriver Indian Hospital, Whiteriver, AZ
Outreach Visits by Pharmacist Improves Adherence to Long-Acting Injectable Antipsychotics in a Rural Setting -
1:45-2:00 PM: Megan Ehret, PharmD, MS, BCPP, Professor, University of Maryland, Baltimore, MD
Training Pharmacy Students to Administer Long-Acting Injectable Medications
Original Research Award
-
2:00-2:15 PM: Jessica Jones, PharmD, BCPP, Clinical Psychiatric Pharmacist, San Diego County Psychiatric Hospital, San Diego, CA
Is a Partial Initiation of Paliperidone Palmitate Effective at Reducing Emergency Psychiatric Encounters? -
2:15-2:30 PM: Monica Zolezzi, MS, PhD, RPh, Assistant Professor, College of Pharmacy, Qatar University, Doha
Words Matter: Analysis of the Language Used When Documenting in the Medical Records of Mental Health Patients
Research Trainee Award
-
2:30-2:45 PM: Delaney Brainerd, PharmD, PGY-2 Psychiatric Pharmacy Resident, Iowa City VA Healthcare System, Iowa City, IA
Clozapine and Risk of Hematologic Malignancies in Veterans with Schizophrenia -
2:45-3:00 PM: Kelly Wylie, MS, Student, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH
A Retrospective Review of Readmission Rates in Patients Initiated on Long-acting Injectable Antipsychotics During Psychiatric Hospitalization
AAPP Foundation Strategic Goals Award
-
3:00-3:15 PM: Margaret Agosta, PharmD, Pharmacist, UC San Diego Health, San Diego, CA
Preliminary Evaluation of Psychiatric Pharmacist Services in the Outpatient Setting -
3:15-3:30 PM: Audrey Long, Student, NDSU, Fargo, ND
Evaluating the Impact of Photovoice on Self-Stigma Levels Among Individuals with Substance Use Concerns
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Austin De La Cruz, PharmD, BCPP
No Relevant Financial Relationships to Disclose
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices. Please indicate drugs and/or devices here: escitalopram used off-label in PNES
Jonathan Leung, PharmD, BCPP, BCPS
Dr. Jonathan G. Leung will be speaking as a consultant for Saladax Biomedical at the 2023 AAPP meeting.
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices. Please indicate drugs and/or devices here: clozapine
Heng Chang, PharmD, BCPS
No Relevant Financial Relationships to Disclose
Megan Ehret, PharmD, MS, BCPP
Financial Interests: Janssen Pharmaceuticals, Otsuka Pharmaceuticals
Jessica Jones, PharmD, BCPP
No Relevant Financial Relationships to Disclose
Monica Zolezzi, MS, PhD, RPh
No Relevant Financial Relationships to Disclose
Delaney Brainerd, PharmD
No Relevant Financial Relationships to Disclose
Kelly Wylie, MS
No Relevant Financial Relationships to Disclose
Margaret Agosta, PharmD
No Relevant Financial Relationships to Disclose
Audrey Long
No Relevant Financial Relationships to Disclose
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.